IPCPR Legislative | FDA


13 Mar FDA Issues Draft Revised Compliance Policy for ENDS Products and Flavored Cigars

This morning, FDA made available a Draft Guidance entitled Modifications to Compliance Policy for Certain Deemed Tobacco Products (March 2019) (Draft Guidance) (attached).  We summarize the Draft Guidance below.   Background The Draft Guidance relates to FDA’s compliance policy for deemed tobacco products (i.e., regulated tobacco products other...

Read More

17 Oct FDA Updates Unified Regulatory Agenda

Earlier today, the US Food and Drug Administration (FDA) updated its roadmap for regulations, called the Unified Regulatory Agenda. This outlines the regulatory priorities and perspective timeline for the FDA and other federal agencies. Importantly, on its agenda, the FDA noted their recent review for premium...

Read More

20 Sep FDA Vapor Announcement Explained

The U.S. Food and Drug Administration has recently announced a flurry of policy directives specifically targeting e-cigarettes or “vapor” products. So what exactly has the FDA announced, and what is the impact or potential impact on IPCPR’s retailers? We’ll unpack both questions below.  What Exactly Did the FDA...

Read More
Questions? Comments? Interested in Getting Involved? Contact the IPCPR Legislative Team!
Thank You. We will contact you as soon as possible.